Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to eMarketer. Obesity drugs have also started showing up in emp ...

Eli Lilly is investing $27 billion in U.S. manufacturing to expand drug production and secure future supply. The company will ...

For the three months ending December 31, 2024, the fund's Retail Class shares gained 1.53%, versus the 2.41% result of the ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Novo Nordisk's NovoCare will now provide uninsured or underinsured patients access to Wegovy for just $499 per month—less ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...